ALK and lymphoid neoplasm: In order to exclude a possible unspecific, toxic effect of the combined treatment, we performed the same experiments in NPM-ALK negative cells derived from a healthy donor as well as in the NPM-ALK negative lymphoid tumor cell line U937 (Table 1, Supplementary Figure S1).